Device Trouble Trips Guidant

 

Guidant's (GDT) shares continued to trade lower Monday following a recall of certain implanted defibrillators, and at least one analyst said the medical-devices maker could now be looking at a lower takeover price from Johnson & Johnson (JNJ).

On Monday, Guidant shares were down $1.51, or 2%, to $70.95. The company said Friday that 50,000 of its implantable cardiac defibrillators in service could be subject to defects that have led to 45 malfunctions. The company has warned doctors worldwide about possible problems with some of the devices. Two patients with defibrillators covered by the notification have died.

After Guidant disclosed the problems with the devices, Johnson & Johnson said it "continues to work toward a third quarter 2005 close of the acquisition of Guidant Corporation. Nonetheless, the events reported by Guidant are serious matters, and Johnson & Johnson is engaged in discussions with Guidant to help the company understand the issues."

Alexander Arrow of Lazard Capital Markets downgraded Guidant to sell from hold on Monday. "We believe the degree of reputational damage to Guidant's ICD franchise, the crown jewel of the company and the main asset JNJ sought in its decision to acquire Guidant, may be becoming great enough to induce JNJ to renegotiate its acquisition price," he wrote in a research note.

Arrow said Guidant initially indicated that implanted defibrillators of more than five years old, which are off-warranty but still at risk for short-circuiting, weren't going to be covered at all.

As of Friday, however, "Guidant apparently changed this stance and began telling doctors it will pay for 100% of the approximately $25,000 per unit that each replacement defibrillator would cost to replace the models that are at risk of failing," Arrow said.

He estimated the cost of the recall could be as much as $225 million. Lazard's capital markets business has been transferred to a privately held entity and is no longer associated with Lazard Freres and its investment banking business.

TheStreet Premium Services    For Personal Service: 877-471-2967

Jim Cramer
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
New: ETF Profits
ETF Profits:
Get money-making ideas from the hottest investment vehicle on the planet. Our experts show you how to play various ETF sectors to help pump-up your portfolio. Learn More
OptionsProfits
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Doug Kass
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
Dow Jones S&P 500 NASDAQ 10-Year Note
12,772.96 1,340.39 2,905.90 19.88
Oil *
117.24
DOWN
117.50
DOWN
11.56
DOWN
21.33
DOWN
0.59
10 Yr
1.99%
SPDR Gold
167.01
-0.91%
-0.86%
-0.73%
-2.88%
Data delayed 20 minutes

Top Stories and Tools

Brokerage Partners

After the Bell

Before the Bell

Booyah! Newsletter

ETF Daily

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.
Podcasts

Connect with TheStreet